Journey Medical (DERM) Operating Expenses (2020 - 2026)

Journey Medical has reported Operating Expenses for 7 years, with the latest figure at $17.5 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 6.01% year-over-year to $17.5 million; the trailing twelve-month figure through Mar 2026 stood at $71.0 million (up 12.46% YoY), and the FY2025 full-year result was $70.0 million, changed 0.31% from the prior year.
• Operating Expenses for Q1 2026 stood at $17.5 million, up from $16.5 million in the prior quarter.
• The five-year high for Operating Expenses was $26.0 million in Q4 2022, with the low at $11.4 million in Q4 2024.
• Historically, Operating Expenses has averaged $20.0 million across 5 years, with a median of $17.9 million in 2025.
• Annual changes were most pronounced in 2022 — Operating Expenses jumped 138.64% — and 2024, when it slumped 34.42%.
• Journey Medical's Operating Expenses stood at $26.0 million in 2022, then sank by 33.13% to $17.4 million in 2023, then tumbled by 34.42% to $11.4 million in 2024, then surged by 45.11% to $16.5 million in 2025, then grew by 5.63% to $17.5 million in 2026.
• The last three Operating Expenses figures came in at $17.5 million (Q1 2026), $16.5 million (Q4 2025), and $19.2 million (Q3 2025), per Business Quant data.